Viewing Study NCT05619367


Ignite Creation Date: 2025-12-25 @ 12:45 AM
Ignite Modification Date: 2025-12-26 @ 1:41 PM
Study NCT ID: NCT05619367
Status: AVAILABLE
Last Update Posted: 2025-12-23
First Post: 2022-11-08
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Compassionate Use (CU) Program of Odronextamab
Sponsor: Regeneron Pharmaceuticals
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module Contacts Locations Module